Glasgow, Scotland (ots/PRNewswire) - Despite meme coins leading the charge in crypto markets in the last couple of years, many still see them as a bit of fun and not a serious investment. But In a recent interview with journalist Emma Robb, Anndy Lian - winner of Best Crypto Advisor 2021 Blockchain Awards - explained why he feels meme coins are a serious investment, ...
Glasgow, Scotland (ots/PRNewswire) - UK boosts commitment to curtail agricultural emissions and reduce climate-induced loss and damage CGIAR urged global leaders today to ensure the 500 million smallholder farmers responsible for up to a third of global food production can adapt to climate change-induced loss and damage. Innovations are needed that can both reduce the ...
Glasgow, Scotland (ots/PRNewswire) - Adults with haemophilia B who received a single dose Refixia® (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed a longer half-life for ...
Glasgow, Scotland (ots/PRNewswire) - A new long term stability study has shown that haemophilia A treatment NovoEight® (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow, UK. Treatment storage issues, ...
London and Glasgow, Scotland (ots/PRNewswire) - Contract designed to kick-start a step change in digital services to support jobs, education, innovation and health for decades to come CGI (NYSE: GIB) (TSX: GIB.A) has been selected by Glasgow City Council (GCC) to provide transformational IT services to enable the introduction of integrated digital services for the ...
Glasgow, Scotland (ots/PRNewswire) - Poster Presentation PDB27 A new analysis of real-world data has shown that switching to Tresiba® (insulin degludec) is highly cost-effective and cost-saving for the treatment of type 1 and type 2 diabetes, respectively.[1] The analysis was presented today at the International Society for Pharmacoeconomics and Outcomes Research ...
Glasgow, Scotland (ots/PRNewswire) - This material is intended for European and UK medical media only. For journalistic assessment and preparation before publication. New findings show that Xultophy® (insulin degludec/liraglutide; IDegLira), the first once-daily combination of a long-acting basal insulin ...